More articles from Other Topics: Poster Presentations - Proffered Abstracts

Abstract A36: Novel therapeutic approaches for human malignant mesothelioma
Haining Yang, Sandro Jube, Michele Carbone

Cancer Immunology Research Oct 2015, 3 (10 Supplement) A36; DOI: 10.1158/2326-6074.TUMIMM14-A36
Abstract A24: Cancer-testis antigen expression is shared among gynecological tumors
Arlene E. Garcia-Soto, Tulay Koru-Sengul, Feng Miao, Taylor Schreiber, Wilberto Nieves-Neira, Eckhard Podack

Cancer Immunology Research Oct 2015, 3 (10 Supplement) A24; DOI: 10.1158/2326-6074.TUMIMM14-A24
Abstract A35: Genomic characterization of immune escape pathways in gastric cancer
Kai Wang, Suet Yi Leung

Cancer Immunology Research Oct 2015, 3 (10 Supplement) A35; DOI: 10.1158/2326-6074.TUMIMM14-A35
Abstract A34: Characterization of tumor infiltrating lymphocytes in human breast cancer by infrared imaging
Magali Verdonck, Soizic Garaud, Laurence Buisseret, Hugues Duvillier, Christine Desmedt, Roland de Wind, Christos Sotiriou, Karen Willard-Gallo, Erik Goormaghtigh

Cancer Immunology Research Oct 2015, 3 (10 Supplement) A34; DOI: 10.1158/2326-6074.TUMIMM14-A34
Abstract A29: Differential expression of the gangliosides GD3 and GD2 in canine and human osteosarcoma cell lines: An immunotherapy target
Rowan J. Milner, Noaki Chimura, Kristina D. Bowles, Marc Salute

Cancer Immunology Research Oct 2015, 3 (10 Supplement) A29; DOI: 10.1158/2326-6074.TUMIMM14-A29
Abstract A33: Preparation of local anti-wart and anti-inflammatory rub of polyglycidol based saturated lipid (DDP-PG) with HPMC containing curcumin
Sharif Mohammad Shaheen, Pavel Bakardzhiev, Denitsa Momekova, Neli S. Koseva, Stanislav Rangelov

Cancer Immunology Research Oct 2015, 3 (10 Supplement) A33; DOI: 10.1158/2326-6074.TUMIMM14-A33
Abstract A28: TRAIL mediated reduction of an immunogenic cell death protein, heat shock protein 70, in glioblastoma
Andrea N. McCray

Cancer Immunology Research Oct 2015, 3 (10 Supplement) A28; DOI: 10.1158/2326-6074.TUMIMM14-A28
Abstract A25: Immunotherapy using LOAd700 armed with CD40 ligand controls experimental pancreatic cancer and activates immune responses
Emma Svensson, Rafael Moreno, Ioanna Milenova, Lisa Christiansson, Ramon Alemany, Angelica Loskog

Cancer Immunology Research Oct 2015, 3 (10 Supplement) A25; DOI: 10.1158/2326-6074.TUMIMM14-A25

Main menu

User menu

Search

More articles from Other Topics: Poster Presentations - Proffered Abstracts

Pages

Articles

Info for

About Cancer Immunology Research